Equities research analysts expect Proto Labs, Inc. (NYSE:PRLB) to post sales of $87.62 million for the current quarter, Zacks reports. Three analysts have made estimates for Proto Labs’ earnings, with the highest sales estimate coming in at $87.70 million and the lowest estimate coming in at $87.55 million. Proto Labs posted sales of $72.35 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 21.1%. The firm is scheduled to announce its next quarterly earnings report on Thursday, February 8th.
On average, analysts expect that Proto Labs will report full-year sales of $87.62 million for the current year, with estimates ranging from $336.70 million to $338.00 million. For the next financial year, analysts expect that the company will post sales of $374.86 million per share, with estimates ranging from $372.70 million to $379.08 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that cover Proto Labs.
Proto Labs (NYSE:PRLB) last announced its earnings results on Thursday, October 26th. The industrial products company reported $0.56 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.52 by $0.04. Proto Labs had a return on equity of 11.63% and a net margin of 14.53%. The company had revenue of $88.10 million for the quarter, compared to analyst estimates of $85.68 million. During the same period in the prior year, the company posted $0.51 EPS. The firm’s quarterly revenue was up 12.7% compared to the same quarter last year.
A number of research analysts have recently weighed in on PRLB shares. Piper Jaffray Companies reissued a “hold” rating and issued a $67.00 price objective on shares of Proto Labs in a report on Friday, July 28th. BidaskClub lowered Proto Labs from a “strong-buy” rating to a “buy” rating in a report on Friday, October 6th. Finally, Zacks Investment Research raised Proto Labs from a “hold” rating to a “buy” rating and set a $96.00 price objective on the stock in a report on Friday, November 3rd. Two analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $69.33.
COPYRIGHT VIOLATION NOTICE: This report was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://sportsperspectives.com/2017/11/11/zacks-analysts-expect-proto-labs-inc-prlb-will-post-quarterly-sales-of-87-62-million.html.
Proto Labs (NYSE:PRLB) opened at $84.75 on Friday. The firm has a market capitalization of $2,240.91, a PE ratio of 48.06, a PEG ratio of 2.25 and a beta of 1.03. Proto Labs has a 1-year low of $48.00 and a 1-year high of $89.95.
Several hedge funds have recently made changes to their positions in PRLB. BlackRock Inc. increased its holdings in shares of Proto Labs by 146,773.4% in the first quarter. BlackRock Inc. now owns 2,905,155 shares of the industrial products company’s stock valued at $148,453,000 after purchasing an additional 2,903,177 shares during the period. Janus Henderson Group PLC increased its holdings in shares of Proto Labs by 411.4% in the second quarter. Janus Henderson Group PLC now owns 1,301,429 shares of the industrial products company’s stock valued at $87,521,000 after purchasing an additional 1,046,960 shares during the period. Victory Capital Management Inc. increased its holdings in shares of Proto Labs by 15,548.3% in the third quarter. Victory Capital Management Inc. now owns 363,509 shares of the industrial products company’s stock valued at $29,190,000 after purchasing an additional 361,186 shares during the period. Lord Abbett & CO. LLC acquired a new stake in Proto Labs during the second quarter worth about $21,351,000. Finally, Bank of New York Mellon Corp grew its holdings in Proto Labs by 44.2% during the second quarter. Bank of New York Mellon Corp now owns 498,198 shares of the industrial products company’s stock worth $33,504,000 after acquiring an additional 152,637 shares during the period.
About Proto Labs
Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related companies with MarketBeat.com's FREE daily email newsletter.